ELEPSIA XR 1500 MG
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
80705-101 -
Package NDC
80705-101-02 -
Package NDC
80705-101-30 -
Package NDC
80705-101-99 -
Application number
NDA204417 -
SPL ID
3c463bee-1191-4cab-b4d0-367673db19ef -
SPL set ID
cac83d47-88a2-4447-a0c0-90b44ffda0ac -
UNII
44YRR34555 -
RxCUI
1605362 -
RxCUI
1605368 -
RxCUI
1605372 -
RxCUI
1605374
What the source publishes
- Labeler
- TRIPOINT THERAPEUTICS, LLC
- Active ingredients
- levetiracetam
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "ELEPSIA XR 1500 MG",
"splId": "3c463bee-1191-4cab-b4d0-367673db19ef",
"labels": [
{
"setId": "cac83d47-88a2-4447-a0c0-90b44ffda0ac",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cac83d47-88a2-4447-a0c0-90b44ffda0ac",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cac83d47-88a2-4447-a0c0-90b44ffda0ac"
}
],
"routes": [
"ORAL"
],
"labeler": "TRIPOINT THERAPEUTICS, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (80705-101-02) / 2 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
"package_ndc": "80705-101-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20210929"
},
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80705-101-30)",
"package_ndc": "80705-101-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20210212"
},
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (80705-101-99) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK",
"package_ndc": "80705-101-99",
"identifierStatus": "well-formed",
"marketing_start_date": "20210212"
}
],
"productId": "80705-101_3c463bee-1191-4cab-b4d0-367673db19ef",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "80705-101",
"deaSchedule": null,
"genericName": "levetiracetam",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LEVETIRACETAM",
"strength": "1500 mg/1"
}
],
"applicationNumber": "NDA204417",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210212",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"upc": [
"0380705101302",
"0380705100305"
],
"unii": [
"44YRR34555"
],
"rxcui": [
"1605362",
"1605368",
"1605372",
"1605374"
],
"spl_set_id": [
"cac83d47-88a2-4447-a0c0-90b44ffda0ac"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"TRIPOINT THERAPEUTICS, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:80705-101_3c463bee-1191-4cab-b4d0-367673db19ef"